Amplification of erbB2 and erbB2 expression are superior to estrogen receptor status as risk factors for distant recurrence in pT1N0M0 breast cancer: a nationwide population-based study.

Heikki Joensuu, Johan Lundin, Vesa Kataja et al.|PubMed|2003

Cited by 209